Health & Biotech
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners
PharmAust extension study begins as analysis shows MND/ALS drug ‘defied the odds’
ASX Health Stocks: Immuron reports record sales for its diarrhoea drug, Travelan
Melodiol subsidiary Mernova expands products in six lucrative Canadian provinces
Countdown on to AdAlta trial results as biotech advances partner discussions
ASX Health Stocks: CSL’s Phase 3 AEGIS-II trial disappoints, fails to meet primary efficacy endpoint
EZZ expands range with launch of three new health and wellness products
ScoPo’s Powerplays: ASX health stocks up as Cochlear upgrades earnings guidance
ASX Health Stocks: Paradigm takes another step forward as Phase 2 trial meets primary endpoint
ASX Health Stocks: Cochlear upgrades guidance, Chimeric up 12pc after commencing Phase 1B trial on leukaemia
Melodiol subsidiaries deliver $2 million revenue to group in strong start to year
ASX Health Stocks: Truscreen to start cervical cancer screening women in Mexico after approval
‘Monumental’– Bioxyne subsidiary awarded Australia’s first GMP licence to manufacture psilocybin and MDMA
ASX Health Stocks: LTP is recruiting for patients to try its erection spray
How big-hearted EBR Systems is pacing a multi-billion dollar cardiac market
Why the buzz for kava is growing, and how The Calmer Co. is capitalising
ASX Health Stocks: Radiopharm’s results published; ProMedicus launches on Apple Vision Pro
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
